Use of sofosbuvir based direct acting antiviral regimens is associated with reduced mortality in liver transplant candidates with hepatitis C Wang, J., Sexter, A., Kim, W., Israni, A. ELSEVIER. 2020: S343-S344

View details for Web of Science ID 000786587001084